Member akshay
Member-
neha posted an update in the group
3 months agoPharma News 3 months agoDigital Roundtables: Redefining Pharma-Physician Engagement
In my daily practice, I’ve noticed how quickly the dynamic between pharmaceutical companies and physicians has shifted—and it’s all moving online. These days, digital roundtables are becoming the primary forum for meaningful engagement.
Instead of crowded conference halls and…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCollaborative Platforms: The New Prescription for Healthcare Innovation
As a doctor, I’ve witnessed how digital collaboration platforms are transforming the healthcare industry. Platforms like HealthSocial allow doctors, researchers, and pharma professionals to exchange ideas instantly — breaking silos that once slowed progress.
Whether it’s…
-
neha posted an update in the group
3 months agoPharma News 3 months agoSupreme Court Clears Natco’s Generic Risdiplam: A Win for Patients, a Lesson for Pharma
As a doctor, I see this week’s Supreme Court verdict — allowing Natco Pharma to launch its generic version of Risdiplam — as a landmark moment for both patients and the healthcare ecosystem. Risdiplam is a life-changing drug for Spinal Muscular Atrophy…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCough Syrup Tragedy Exposes Fragility in India’s Drug Safety Oversight
As a clinician deeply invested in both patient safety and pharmaceutical integrity, recent events surrounding contaminated cough syrups in India have shaken me to the core. This isn’t just “another pharma scandal” — it’s a stark warning that regulatory gaps, quality lapses,…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoThe Rise of Indian Pharma Exports: What It Means for Healthcare Professionals
As a doctor, I’ve always viewed India’s pharmaceutical sector with a sense of pride — it’s often called “the pharmacy of the world.” Over the past decade, Indian pharma exports have grown remarkably, supplying affordable and quality medicines to more than 200…
-
neha posted an update in the group
3 months agoPharma News 3 months agoIndia’s Pharma Evolution: A Doctor’s Perspective on Progress and Responsibility
As a practising doctor, I see the rapid transformation of India’s pharmaceutical industry not just as industry news, but as something that directly impacts patient care, prescribing habits, and trust in our healthcare system.
Affordability remains a key focus. The…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoIndia’s Premier Med Systems Investing ₹60 Crore to Expand Device Manufacturing at Noida Park
As a physician who often deals with shortages or long lead times for imaging and critical care equipment, this update is very encouraging. Premier Medical Systems (Medisys), one of India’s earliest medical-equipment makers, has secured a letter of…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Medical Device Market Poised for Significant Growth by 2033
India’s medical device market is set to expand from USD 6.82 billion in 2025 to approximately USD 12.57 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.00%. This growth is driven by increased healthcare investment, government support, and…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoIndia’s Drug Regulatory Authority Approves Eight New Medicines in 2025, Expanding Treatment Options Across Multiple Therapeutic Areas
The Central Drugs Standard Control Organisation (CDSCO) has approved eight new medicines in 2025, marking a significant step forward in India’s healthcare sector. These approvals encompass a range of…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoSafer Eye Chemo for Kids: Intravitreal Topotecan Success in Retinoblastoma
In Hyderabad, the LV Prasad Eye Institute (LVPEI) ran a study in children with retinoblastoma (a rare but serious eye cancer). Traditionally, recurrences or resistant tumors are treated with intravitreal injections of melphalan, but at higher doses that can damage…
-
neha posted an update in the group
4 months agoPharma News 4 months agoIndia’s Push for Biosimilars: Affordable Access to Life-Saving Drugs
In oncology and autoimmune care, I often see patients forced to discontinue treatment because the original biologic drug is too expensive. This is where biosimilars — near-identical versions of complex biologics — are changing lives in India.
Recently, Indian pharma…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoWearables: The Next Step Toward Truly Personalized Medicine
Recently, one of my heart patients showed me how his smartwatch had picked up irregular beats before he even felt symptoms. That moment reminded me how far we’ve come — and how much further we can go.
Wearables today track heart rate, sleep, oxygen levels, and even stress. But what…
-
neha posted an update in the group
4 months agoPharma News 4 months agoHow Companion Diagnostics Are Transforming Prescriptions
One change I’ve noticed in recent years is that prescribing is no longer just about choosing a drug — it’s about choosing the right drug for the right patient, backed by a diagnostic test. These are called companion diagnostics, and they’re becoming more common in cancer, infectious…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoThe Changing Face of Modern Medicine
When I look back at how I practiced medicine even a decade ago, the changes in our industry feel nothing short of remarkable.
Take diagnostics — once, waiting for CT or MRI reports could delay treatment decisions. Today, with faster imaging and AI-assisted reporting, I often get actionable insights within…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoHow AI Is Quietly Changing My Daily Practice
As a doctor, I sometimes forget how much of the medicines I prescribe today are shaped by AI working behind the scenes in pharma. It’s no longer just futuristic — I see it in daily practice.
Consider antibiotics. With resistance rising, I often worry if I’m choosing the right one. Now, pharma…
-
neha posted an update in the group
4 months agoPharma News 4 months agoWhy I Trust Generics — But Double-Check Every Time
In my practice, I prescribe generics frequently. A few months ago, I had a patient with high cholesterol who could not afford a branded statin. I shifted him to a generic version. Within 6 weeks, his LDL had dropped beautifully, and his follow-up labs looked great.
But another patient on a…
-
akshay posted an update in the group
4 months agoPharma News 4 months agoIndia’s Regulatory System Is Turning More Digital, Faster, More Innovation-Friendly
Several changes are underway that affect us in clinical practice:
-
The DCGI / CDSCO is pushing faster drug approvals, especially for rare disease therapies and advanced treatments (like gene therapies).
-
Drug licensing systems are being digitized: state + central…
-
-
prajudude01 posted an update in the group
5 months agoPharma News 5 months agoThe active pharmaceutical ingredient (API) for cancer market has been witnessing robust growth, driven by the rising global burden of cancer and the increasing demand for advanced therapies. APIs are the essential components of cancer drugs, directly responsible for their therapeutic effects. With oncology being one of the most dynamic…
